Harmonized Diagnostic Assessment of Dementia (DAD) for Longitudinal Aging Study in India (LASI) Genomic Study-Covid-19 Administrative Supplement Year 2

印度纵向衰老研究 (LASI) 基因组研究的痴呆症统一诊断评估 (DAD) - Covid-19 行政补充第 2 年

基本信息

  • 批准号:
    10309409
  • 负责人:
  • 金额:
    $ 40.64万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-15 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary The COVID-19 pandemic poses grave risks to countries across the globe. India may be particularly vulnerable as it has relatively weak health systems, high population density, a growing non-communicable disease burden, and a large low-income population. Since May 2020, we have developed and administered a bi- monthly phone survey which will continue over the course of 12 months, tracking the knowledge of and attitude toward COVID-19, as well as monitoring changes in the respondents’ health, cognition, health care utilization, and household income and consumption, for a large subsample of the Harmonized Diagnostic Assessment of Dementia for the Longitudinal Aging Study in India. The Harmonized Diagnostic Assessment of Dementia for the Longitudinal Aging Study in India (LASI-DAD) is the first and only nationally representative and publicly available dataset on late-life cognition and dementia in India. It administers the Harmonized Cognitive Assessment Protocol (HCAP) that is designed to be harmonized with ongoing longitudinal studies of aging around the world, including the Health and Retirement Study (HRS) in the United States and prior studies in India. This rich set of cognitive phenotypes and a variety of other health and social environment phenotypes, as well as genotype data from whole genome sequencing, give us a unique opportunity to identify the mutational spectrum underlying the risk of dementia and AD in a representative sample in India. In this application, we aim to conduct two additional rounds of phone surveys over the following 12-month period after the conclusion of the current one-year period to capture longer term effects of the COVID pandemic. The pandemic has influenced everyday lives, and it is likely that these effects may be sustained in the longer term. In order to capture such prolonged effects, we aim to collect two additional rounds of data over a 12-month time period. Leveraging the first wave of LASI-DAD, we will then investigate how COVID-19- related changes in the social, economic, and policy environments differentially impact the respondents’ health, particularly cognition and dementia. We will also aim to release data to the wider research community so all interested researchers will have access to eight rounds of rich, nationally representative panel data throughout and after the pandemic.
项目摘要 COVID-19疫情对地球仪各国构成严重风险。印度可能特别脆弱 由于其卫生系统相对薄弱、人口密度高、非传染性疾病日益严重, #21453;,以及大量低收入人口。自2020年5月以来,我们制定并管理了一个双- 每月电话调查,将持续12个月,跟踪知识和态度 对COVID-19的反应,以及监测受访者的健康,认知,医疗保健利用, 和家庭收入和消费,对一个大的子样本的统一诊断评估, 印度老年痴呆症纵向研究。 印度纵向老龄化研究中痴呆症的统一诊断评估(LASI-DAD) 是第一个也是唯一一个关于晚年认知和痴呆症的全国代表性和公开数据集 在印度它管理协调认知评估协议(HCAP),旨在 与世界各地正在进行的老龄化纵向研究相协调,包括健康和退休 美国的研究(HRS)和印度的既往研究。这种丰富的认知表型和各种 其他健康和社会环境表型,以及来自全基因组测序的基因型数据, 这为我们提供了一个独特的机会来确定痴呆和AD风险背后的突变谱, 印度的代表性样本。 在这项申请中,我们的目标是在接下来的12个月内进行另外两轮电话调查 于本一年期间结束后之期间内,以捕捉COVID之较长期影响 流行病这一流行病影响了日常生活,这些影响可能会持续到2010年。 更长远的计划为了捕捉这种长期影响,我们的目标是收集两轮额外的数据, 12个月的时间。利用LASI-DAD的第一波,我们将研究COVID-19- 社会、经济和政策环境的相关变化对受访者的健康产生不同的影响, 尤其是认知和痴呆症。我们还将致力于向更广泛的研究界发布数据, 感兴趣的研究人员将有机会获得八轮丰富的,全国代表性的面板数据, 在大流行之后。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sharon L Kardia其他文献

1093-146 The association of plasma homocysteine with coronary artery atherosclerosis is modified by conventional risk factors
  • DOI:
    10.1016/s0735-1097(04)91419-2
  • 发表时间:
    2004-03-03
  • 期刊:
  • 影响因子:
  • 作者:
    Itikhar J Kullo;Kent R Bailey;Lawrence F Bielak;Sharon L Kardia;Patrick F Sheedy;Patricia A Peyser;Stephen T Turner
  • 通讯作者:
    Stephen T Turner

Sharon L Kardia的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sharon L Kardia', 18)}}的其他基金

Harmonized Diagnostic Assessment of Dementia (DAD) for Longitudinal Aging Study of India (LASI)-Genomic study
印度纵向衰老研究 (LASI) 的痴呆症统一诊断评估 (DAD) 基因组研究
  • 批准号:
    10836795
  • 财政年份:
    2019
  • 资助金额:
    $ 40.64万
  • 项目类别:
Harmonized Diagnostic Assessment of Dementia (DAD) for Longitudinal Aging Study of India (LASI)-Genomic study.
印度纵向衰老研究 (LASI) 基因组研究的痴呆症统一诊断评估 (DAD)。
  • 批准号:
    10017825
  • 财政年份:
    2019
  • 资助金额:
    $ 40.64万
  • 项目类别:
Harmonized Diagnostic Assessment of Dementia (DAD) for Longitudinal Aging Study of India (LASI)-Genomic study.
印度纵向衰老研究 (LASI) 基因组研究的痴呆症统一诊断评估 (DAD)。
  • 批准号:
    10237323
  • 财政年份:
    2019
  • 资助金额:
    $ 40.64万
  • 项目类别:
Harmonized Diagnostic Assessment of Dementia (DAD) for Longitudinal Aging Study of India (LASI)-Genomic study.
印度纵向衰老研究 (LASI) 基因组研究的痴呆症统一诊断评估 (DAD)。
  • 批准号:
    10685990
  • 财政年份:
    2019
  • 资助金额:
    $ 40.64万
  • 项目类别:
Harmonized Diagnostic Assessment of Dementia (DAD) for Longitudinal Aging Study of India (LASI)-Genomic study.
印度纵向衰老研究 (LASI) 基因组研究的痴呆症统一诊断评估 (DAD)。
  • 批准号:
    10474359
  • 财政年份:
    2019
  • 资助金额:
    $ 40.64万
  • 项目类别:
Genetic Mechanisms of Arteriosclerosis in Hypertensive Sibships
高血压同胞动脉硬化的遗传机制
  • 批准号:
    8918019
  • 财政年份:
    2014
  • 资助金额:
    $ 40.64万
  • 项目类别:
Genetic Mechanisms of Arteriosclerosis in Hypertensive Sibships
高血压同胞动脉硬化的遗传机制
  • 批准号:
    9302511
  • 财政年份:
    2014
  • 资助金额:
    $ 40.64万
  • 项目类别:
Genetic Mechanisms of Arteriosclerosis in Hypertensive Sibships
高血压同胞动脉硬化的遗传机制
  • 批准号:
    8758883
  • 财政年份:
    2014
  • 资助金额:
    $ 40.64万
  • 项目类别:
Genetic and Psychosocial Predictors of Blood Pressure and Body Mass Index
血压和体重指数的遗传和社会心理预测因素
  • 批准号:
    8738570
  • 财政年份:
    2013
  • 资助金额:
    $ 40.64万
  • 项目类别:
Genetic and Psychosocial Predictors of Blood Pressure and Body Mass Index
血压和体重指数的遗传和社会心理预测因素
  • 批准号:
    8617892
  • 财政年份:
    2013
  • 资助金额:
    $ 40.64万
  • 项目类别:

相似海外基金

Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
  • 批准号:
    24K18114
  • 财政年份:
    2024
  • 资助金额:
    $ 40.64万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
  • 批准号:
    10089306
  • 财政年份:
    2024
  • 资助金额:
    $ 40.64万
  • 项目类别:
    Collaborative R&D
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
  • 批准号:
    498288
  • 财政年份:
    2024
  • 资助金额:
    $ 40.64万
  • 项目类别:
    Operating Grants
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
  • 批准号:
    498310
  • 财政年份:
    2024
  • 资助金额:
    $ 40.64万
  • 项目类别:
    Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
  • 批准号:
    23K20339
  • 财政年份:
    2024
  • 资助金额:
    $ 40.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
  • 批准号:
    2740736
  • 财政年份:
    2024
  • 资助金额:
    $ 40.64万
  • 项目类别:
    Studentship
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
  • 批准号:
    2305890
  • 财政年份:
    2024
  • 资助金额:
    $ 40.64万
  • 项目类别:
    Fellowship Award
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
  • 批准号:
    2406592
  • 财政年份:
    2024
  • 资助金额:
    $ 40.64万
  • 项目类别:
    Standard Grant
McGill-MOBILHUB: Mobilization Hub for Knowledge, Education, and Artificial Intelligence/Deep Learning on Brain Health and Cognitive Impairment in Aging.
McGill-MOBILHUB:脑健康和衰老认知障碍的知识、教育和人工智能/深度学习动员中心。
  • 批准号:
    498278
  • 财政年份:
    2024
  • 资助金额:
    $ 40.64万
  • 项目类别:
    Operating Grants
Welfare Enhancing Fiscal and Monetary Policies for Aging Societies
促进老龄化社会福利的财政和货币政策
  • 批准号:
    24K04938
  • 财政年份:
    2024
  • 资助金额:
    $ 40.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了